Colonic washout enemas for persistent constipation in children with recurrent urinary tract infections based on

Rafal Chrzan1, Aart J Klijn, Marianne A W Vijverberg

  • 1Paediatric Renal Centre, University Children's Hospital, UMC Utrecht, The Netherlands. rchrzan@umcutrecht.nl

Urology
|February 26, 2008
PubMed

Insights

Colonic washout enemas effectively treat persistent constipation in children with dysfunctional voiding when oral laxatives fail. This method normalized rectal diameter and improved symptoms in most patients, offering a viable treatment option.

Area of Science:

  • Pediatric Gastroenterology
  • Urology
  • Colorectal Surgery

Background:

  • Dysfunctional voiding in children often coexists with persistent constipation and rectal dilatation.
  • Standard oral laxative therapies may be insufficient for managing severe constipation in this population.

Purpose of the Study:

  • To evaluate the efficacy and safety of colonic washout enemas for children with persistent constipation and dysfunctional voiding.
  • To assess the impact of washout enemas on rectal diameter and associated symptoms.

Main Methods:

  • Fifty children with dysfunctional voiding and rectal dilatation, unresponsive to oral laxatives, received colonic washout enemas.
  • Treatment involved retrograde rectal filling with water (20 mL/kg), initially daily, then 3 times weekly for 6-12 months.
  • Rectal diameter was assessed via ultrasound, and symptom relief was monitored over a 6-month follow-up period.

Main Results:

  • Thirty children achieved resolution of urinary tract infections, and 20 experienced partial symptom relief.
  • All patients demonstrated normalized rectal diameter on ultrasound post-treatment.
  • Washout therapy was successfully discontinued in 33 patients; 17 required intermittent enemas for relapse prevention. Minimal pain was reported, with no significant adverse effects.

Conclusions:

  • Colonic washout enemas represent a successful therapeutic option for children with dysfunctional voiding and constipation refractory to oral laxatives.
  • The treatment normalizes rectal diameter and can lead to sustained symptom improvement, potentially reducing the need for long-term laxative use.
Abstract

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Imaging Studies VI: Voiding Cystourethrography and Cystography01:22

Imaging Studies VI: Voiding Cystourethrography and Cystography

Voiding Cystourethrography (VCUG) and Cystography are specialized radiographic procedures used to examine the structure and function of the bladder and urethra.Voiding Cystourethrography (VCUG)A Voiding Cystourethrogram (VCUG) is a diagnostic imaging procedure that assesses the anatomy and function of the lower urinary tract. It focuses on the bladder, bladder neck, and urethra, helping detect abnormalities such as vesicoureteral reflux (VUR)—the backward or reverse flow of urine into the...